Citius Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$1.17(as of Sep 22, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Citius Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.17
Ticker SymbolCTXR
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees23
CountyUSA
Market Cap$20.2M
EBIDTA-41.1M
10-Day Moving Average1.18
P/E Ratio-0.31
20-Day Moving Average1.23
Forward P/E Ratio1.82
50-Day Moving Average1.34
Earnings per Share-4.87
200-Day Moving Average1.73
Profit Margin-Infinity%
RSI42.04
Shares Outstanding17.0M
ATR0.09
52-Week High13.78
Volume358,179
52-Week Low0.65
Most Recent Support Level1.13
Book Value67.6M
Most Recent Resistance Level1.25
P/B Ratio0.19
Upper Keltner1.42
P/S Ratio81.88
Lower Keltner1.04
Debt-to-Equity Ratio1.42
Next Earnings DateUnknown
Cash Surplus-45.8M
Next Ex-Dividend DateUnknown

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Citius Pharmaceuticals Inc In Our Stock Scanner

As of Sep 23, 2025
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.